Certolizumab pegol

Gil Melmed

doi:10.1038/nrd2654

2008-08-01

PRE

DOI：10.1038/nrd2654

原文求助

摘要

Keyword:

INFLAMMATORY-BOWEL-DISEASE

CROHNS-DISEASE

RANDOMIZED-TRIAL

NECROSIS-FACTOR

THERAPY

MAINTENANCE

ADALIMUMAB

AI总结

对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Nature Reviews Drug Discovery

IF:

101.8

论文数:

5.1K

被引数:

5.3W

机构

University of California System

学者数:

37.5W

论文数: 33.7W

被引数: 6.6K

Cedars Sinai Medical Center

学者数:

1.3W

论文数: 1.1W

被引数: 23

引用论文

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

GASTROENTEROLOGY

IF25.1

2004-05-01

2.6K

OAAI

Loftus, EV

C-OFDMA: Improved Throughput for Next Generation WLAN Systems Based on OFDMA and CSMA/CA

2013 4th International Conference on Intelligent Systems, Modelling and Simulation

IF0

2013-01-01

PREAI

G. Haile; Jaesung Lim

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial

LANCET

IF88.5

2008-02-01

1.0K

PREAI

D'Haens, Geert; Baert, Filip; van Assche, Gert; Caenepeel, Philip; Vergauwe, Philippe; Tuynman, Hans; De Vos, Martine; van Deventer, Sander; Stitt, Larry; Donner, Allan; Vermeire, Severine; Van De Mierop, Frank J.; Coche, Jean-Charles R.; van der Woude, Janneke; Ochsenkuehn, Thomas; van Bodegraven, Ad A.; van Hootegem, Philippe P.; Lambrecht, Guy L.; Mana, Fazia; Rutgeerts, Paul; Feagan, Brian G.; Hommes, Daniel

Maintenance therapy with certolizumab pegol for Crohn's disease

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2007-07-19

883

OAAI

Schreiber, Stefan; Khaliq-Kareemi, Mani; Lawrance, Ian C.; Thomsen, Ole Ostergaard; Hanauer, Stephen B.; McColm, Juliet; Bloomfield, Ralph; Sandborn, William J.

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

1997-10-09

2.9K

OAAI

Targan, SR; Hanauer, SB; vanDeventer, SJH; Mayer, L; Present, DH; Braakman, T; DeWoody, KL; Schaible, TF; Rutgeerts, PJ

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2008-06-01

503

OAAI

Peyrin-Biroulet, Laurent; Deltenre, Pierre; De Suray, Nicolas; Branche, Julien; Sandborn, William J.; Colombel, Jean-Frederic

The immunological and genetic basis of inflammatory bowel disease

NATURE REVIEWS IMMUNOLOGY

IF60.9

2003-07-01

1.6K

PREAI

Bouma, G; Strober, W

Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial

ANNALS OF INTERNAL MEDICINE

IF15.2

2007-06-19

837

PREAI

Sandborn, William J.; Rutgeerts, Paul; Enns, Robert; Hanauer, Stephen B.; Colombel, Jean-Frederic; Panaccione, Remo; D'Haens, Geert; Li, Ju; Rosenfeld, Marie R.; Kent, Jeffrey D.; Pollack, Paul F.

Certolizumab pegol for the treatment of Crohn's disease

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2007-07-19

939

OAAI

Sandborn, William J.; Feagan, Brian G.; Stoinov, Simeon; Honiball, Pieter J.; Rutgeerts, Paul; Mason, David; Bloomfield, Ralph; Schreiber, Stefan

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial

GASTROENTEROLOGY

IF25.1

2007-01-01

1.8K

PREAI

Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul; Enns, Robert; Hanauer, Stephen B.; Panaccione, Remo; Schreiber, Stefan; Byczkowski, Dan; Li, Ju; Kent, Jeffrey D.; Pollack, Paul F.

查看更多内容